• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后复发性膜性肾病中补体受体1的增强:一例报告

Complement Receptor 1 Enhancement in Recurrent Membranous Nephropathy Following Kidney Transplantation: A Case Report.

作者信息

Kounoue Noriyuki, Oguchi Hideyo, Hashiguchi Akinori, Honda Kazuho, Kang Dedong, Mikami Tetuo, Tochigi Naobumi, Kawamura Takeshi, Itabashi Yoshihiro, Yonekura Takashi, Sakurabayashi Kei, Sakai Ken

机构信息

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Department of Nephrology, Toho University Graduate School of Medicine, Tokyo, Japan.

出版信息

Kidney Med. 2024 Jul 20;6(9):100876. doi: 10.1016/j.xkme.2024.100876. eCollection 2024 Sep.

DOI:10.1016/j.xkme.2024.100876
PMID:39247399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11380390/
Abstract

Membranous nephropathy (MN) recurs in some kidney allograft patients, and recurrence increases graft failure rates. We present a unique case of recurrent MN in first and second allografts showing glomerular capillary wall-positivity for complement receptor 1 (CR1) consistent with immunoglobulin G (IgG). A man in his late 20s developed MN and started hemodialysis. MN recurred and caused graft loss after the first transplantation and recurred again soon after the second transplantation. The IgG subclass staining was almost consistently negative for IgG4 and phospholipase A2 receptor (PLA2R)-staining was negative. Recurrent MN of unknown etiology was considered. Mass spectrometry demonstrated that CR1 had increased in the transplanted kidney biopsies. Immunohistochemistry and immunofluorescence studies demonstrated CR1 colocalized with IgG along glomerular capillaries in this case, whereas CR1 was localized in podocytes with no colocalization of IgG in a control case of PLA2R-associated MN. Correlative light and immunoelectron microscopy showed localization of CR1 at the interface between electron-dense deposits and podocytes. Collectively, this case demonstrated a unique enhancement and localization of CR1. MN with enhancement of CR1 has not been reported to date. CR1 may be a candidate causative antigen in this case of recurrent MN, although further study is needed to investigate the pathogenesis of CR1.

摘要

膜性肾病(MN)在一些肾移植受者中会复发,复发会增加移植肾失功的发生率。我们报告了一例独特的复发性MN病例,该病例在首次和第二次移植肾中均出现复发,其肾小球毛细血管壁上补体受体1(CR1)呈阳性,与免疫球蛋白G(IgG)一致。一名20多岁的男性患MN并开始接受血液透析。首次移植后MN复发并导致移植肾失功,第二次移植后不久再次复发。IgG亚类染色几乎始终为IgG4阴性,磷脂酶A2受体(PLA2R)染色为阴性。考虑为病因不明的复发性MN。质谱分析显示移植肾活检组织中CR1增加。免疫组织化学和免疫荧光研究表明,在该病例中CR1与IgG沿肾小球毛细血管共定位,而在PLA2R相关性MN的对照病例中,CR1定位于足细胞,无IgG共定位。相关的光学和免疫电子显微镜检查显示CR1定位于电子致密沉积物与足细胞之间的界面。总体而言,该病例显示了CR1独特的增强和定位。迄今为止,尚未报道过CR1增强的MN。在该复发性MN病例中,CR1可能是候选致病抗原,尽管需要进一步研究以探讨CR1的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c102/11380390/9585bce4588e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c102/11380390/8832b6f46b52/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c102/11380390/9585bce4588e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c102/11380390/8832b6f46b52/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c102/11380390/9585bce4588e/gr2.jpg

相似文献

1
Complement Receptor 1 Enhancement in Recurrent Membranous Nephropathy Following Kidney Transplantation: A Case Report.肾移植后复发性膜性肾病中补体受体1的增强:一例报告
Kidney Med. 2024 Jul 20;6(9):100876. doi: 10.1016/j.xkme.2024.100876. eCollection 2024 Sep.
2
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor.同种异体移植后由 IgG3κ 靶向 PLA2R 引起的复发性膜性肾病。
J Am Soc Nephrol. 2012 Dec;23(12):1949-54. doi: 10.1681/ASN.2012060577. Epub 2012 Nov 2.
3
Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.肾移植后与磷脂酶A2受体相关的复发性膜性肾病并成功接受利妥昔单抗治疗:一例报告
Transplant Proc. 2018 Oct;50(8):2565-2568. doi: 10.1016/j.transproceed.2018.03.083. Epub 2018 Mar 19.
4
Combined evaluation of glomerular phospholipase A2 receptor and immunoglobulin G subclass in membranous nephropathy.膜性肾病中肾小球磷脂酶A2受体与免疫球蛋白G亚类的联合评估
Clin Kidney J. 2024 Apr 17;17(6):sfae104. doi: 10.1093/ckj/sfae104. eCollection 2024 Jun.
5
Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.中国膜性肾病患者肾小球沉积物中磷脂酶A2受体及IgG亚类的回顾性研究
PLoS One. 2016 May 25;11(5):e0156263. doi: 10.1371/journal.pone.0156263. eCollection 2016.
6
Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy.特发性及恶性肿瘤相关性膜性肾病中的肾小球IgG亚类
Clin Kidney J. 2015 Aug;8(4):433-9. doi: 10.1093/ckj/sfv049. Epub 2015 Jul 9.
7
Clinicopathological study of de novo membranous nephropathy of 'stage 0' after kidney transplantation.肾移植后“0期”新发膜性肾病的临床病理研究
Nephrology (Carlton). 2018 Jul;23 Suppl 2:63-69. doi: 10.1111/nep.13274.
8
Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.同卵双胞胎活体供肾移植术后很久出现的磷脂酶A2受体阳性膜性肾病
Nephrology (Carlton). 2015 Jul;20 Suppl 2:101-4. doi: 10.1111/nep.12458.
9
HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.在新发膜性肾病的肾移植中,HLA - DR而非PLA2R在足细胞上表达。
Medicine (Baltimore). 2016 Sep;95(37):e4809. doi: 10.1097/MD.0000000000004809.
10
Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.日本M型磷脂酶A2受体(PLA2R)相关膜性肾病的临床病理特征
Clin Exp Nephrol. 2015 Oct;19(5):797-803. doi: 10.1007/s10157-014-1064-0. Epub 2014 Dec 10.

本文引用的文献

1
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy.丝氨酸蛋白酶HTRA1作为原发性膜性肾病中的一种新型靶抗原。
J Am Soc Nephrol. 2021 Jul;32(7):1666-1681. doi: 10.1681/ASN.2020101395. Epub 2021 May 5.
2
Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.确立膜性肾病抗补体治疗的依据
Kidney Int Rep. 2020 Dec 13;6(2):484-492. doi: 10.1016/j.ekir.2020.11.032. eCollection 2021 Feb.
3
Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients.
信号素3B相关膜性肾病是一种主要见于儿科患者的独特疾病类型。
Kidney Int. 2020 Nov;98(5):1253-1264. doi: 10.1016/j.kint.2020.05.030. Epub 2020 Jun 11.
4
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.神经表皮生长因子样 1 蛋白(NELL-1)相关膜性肾病。
Kidney Int. 2020 Jan;97(1):163-174. doi: 10.1016/j.kint.2019.09.014. Epub 2019 Oct 7.
5
Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.外显素 1/外显素 2 相关的膜性肾病。
J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6.
6
Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.移植肾后复发性肾小球肾炎:危险因素和移植物结局。
Kidney Int. 2017 Aug;92(2):461-469. doi: 10.1016/j.kint.2017.03.015.
7
Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.补体受体1(CR1;CD35)在上皮细胞中的作用:理解补体介导的肾脏损伤的模型。
Mol Immunol. 2015 Oct;67(2 Pt B):584-95. doi: 10.1016/j.molimm.2015.07.016. Epub 2015 Aug 7.
8
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.特发性膜性肾病中的含血小板反应蛋白1型结构域7A
N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.
9
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
10
Risk of renal allograft loss from recurrent glomerulonephritis.复发性肾小球肾炎导致肾移植失败的风险。
N Engl J Med. 2002 Jul 11;347(2):103-9. doi: 10.1056/NEJMoa013036.